NorthWest Biotherapeutics Inc (NWBO)

[Galzus Research]

I have gone into detail as to what the criticisms of the trial are from other GBM experts. I did not rehash them in detail because my other article is still available

I didn’t “ignore” anything with respect to the authors. I refer you to my lengthy discourse on other phase 3 trials that have critiques. I have questions that have not been answered here, and I think that’s telling.

If you can answer the questions I posed, then you’ll understand why I don’t feel having 73 authors on a paper is worth as much as this board does. I won’t retype my arguments that continue to be ignored